bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 19, 2024
The
majority
of
studies
on
extracellular
vesicles
(EVs)
focused
samples
isolated
from
liquid
matrices,
such
as
cell
culture
media
and
blood,
due
to
their
accessibility.
However,
recent
research
highlights
the
emerging
roles
EVs
derived
solid
tissues,
including
brain,
muscles
tumors.
Investigating
matrix
tissues
offers
insights
into
microenvironment
potential
biological
influences
surrounding
cells.
This
study
presents
a
method
for
comparing
EV-enriched
(human
skeletal
muscle
biopsy)
(plasma)
addressing
technical
challenges
minimizing
biases
in
separation
techniques.
By
employing
optimized
protocols
advanced
analytical
techniques,
reveals
differences
biochemical
composition,
nanomechanical
properties,
particle
yield,
size
distribution,
colloidal
stability
between
human
plasma
EVs.
Understanding
these
distinctions
may
contribute
development
novel
diagnostic
assays
muscular
pathologies
shed
light
EVs'
diverse
tissue
environments.
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(6), P. 709 - 709
Published: May 24, 2024
Of
all
the
numerous
nanosized
extracellular
vesicles
released
by
a
cell,
endosomal-originated
exosomes
are
increasingly
recognized
as
potential
therapeutics,
owing
to
their
inherent
stability,
low
immunogenicity,
and
targeted
delivery
capabilities.
This
review
critically
evaluates
transformative
of
exosome-based
modalities
across
pharmaceutical
precision
medicine
landscapes.
Because
precise
biomolecular
cargo
delivery,
posited
ideal
candidates
in
drug
enhancing
regenerative
strategies,
advancing
diagnostic
technologies.
Despite
significant
market
growth
projections
exosome
therapy,
its
utilization
is
encumbered
substantial
scientific
regulatory
challenges.
These
include
lack
universally
accepted
protocols
for
isolation
complexities
associated
with
navigating
environment,
particularly
guidelines
set
forth
U.S.
Food
Drug
Administration
(FDA).
presents
comprehensive
overview
current
research
trajectories
aimed
at
addressing
these
impediments
discusses
prospective
advancements
that
could
substantiate
clinical
translation
exosomal
therapies.
By
providing
analysis
both
capabilities
hurdles
therapeutic
applications,
this
article
aims
inform
direct
future
paradigms,
thereby
fostering
integration
systems
into
mainstream
practice.
Journal of Extracellular Vesicles,
Journal Year:
2023,
Volume and Issue:
12(8)
Published: July 25, 2023
Extracellular
vesicles
(EVs)
are
increasingly
gaining
interest
as
biomarkers
and
therapeutics.
Accurate
sizing
quantification
of
EVs
remain
problematic,
given
their
nanometre
size
range
small
scattering
cross-sections.
This
is
compounded
by
the
fact
that
common
EV
isolation
methods
result
in
co-isolation
particles
with
comparable
features.
Especially
blood
plasma,
similarly-sized
lipoproteins
outnumber
to
a
great
extent.
Recently,
interferometric
nanoparticle
tracking
analysis
(iNTA)
was
introduced
particle
method
enables
determining
refractive
index
nanoparticles
high
sensitivity
precision.
In
this
work,
we
apply
iNTA
differentiate
between
lipoproteins,
compare
its
performance
conventional
(NTA).
We
show
can
accurately
quantify
artificial
EV-lipoprotein
mixtures
plasma-derived
samples
varying
complexity.
Conventional
NTA
could
not
report
on
numbers,
it
able
distinguish
from
lipoproteins.
has
potential
become
new
standard
for
label-free
characterization
suspension.
Journal of Extracellular Vesicles,
Journal Year:
2023,
Volume and Issue:
12(10)
Published: Oct. 1, 2023
The
widely
overlapping
physicochemical
properties
of
lipoproteins
(LPs)
and
extracellular
vesicles
(EVs)
represents
one
the
main
obstacles
for
isolation
characterization
these
pervasive
biogenic
lipid
nanoparticles.
We
herein
present
application
an
atomic
force
microscopy
(AFM)-based
quantitative
morphometry
assay
to
rapid
nanomechanical
screening
mixed
LPs
EVs
samples.
method
can
determine
diameter
mechanical
stiffness
hundreds
individual
nanometric
objects
within
few
hours.
obtained
diameters
are
in
accord
with
those
measured
via
cryo-electron
(cryo-EM);
assignment
specific
readout
each
object
enables
simultaneous
discrimination
co-isolated
even
if
they
have
size
distributions.
all
classes
shown
be
characterised
by
combinations
stiffness,
thus
making
it
possible
estimate
their
relative
abundance
EV/LP
samples
terms
stoichiometric
ratio,
surface
area
volume.
As
a
side
finding,
we
show
how
behaviour
LP
is
correlated
distinctive
structural
features
revealed
cryo-EM.
described
approach
label-free,
single-step
relatively
quick
perform.
Importantly,
used
analyse
which
prove
very
challenging
assess
several
established
techniques
due
ensemble-averaging,
low
sensibility
small
particles,
or
both,
providing
useful
tool
quickly
assessing
purity
isolates
including
plasma-
serum-derived
preparations.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(29)
Published: May 31, 2024
Abstract
Extracellular
vesicles
(EVs),
crucial
mediators
of
cell‐to‐cell
communication,
hold
significant
diagnostic
potential
due
to
their
ability
concentrate
protein
biomarkers
in
bodily
fluids.
However,
challenges
isolating
EVs
from
biological
specimens
hinder
widespread
use.
The
preferred
strategy
involves
direct
analysis,
integrating
isolation
and
analysis
solutions,
with
immunoaffinity
methods
currently
dominating.
Yet,
the
heterogeneous
nature
poses
challenges,
as
proposed
markers
may
not
be
universally
present
thought,
raising
concerns
about
biomarker
screening
reliability.
This
issue
extends
EV‐mimics,
where
conventional
lack
applicability.
Addressing
these
study
reports
on
Membrane
Sensing
Peptides
(MSP)
pan‐vesicular
affinity
ligands
for
both
non‐canonical
analogs,
streamlining
capture
phenotyping
through
Single
Molecule
Array
(SiMoA).
MSP
enable
circulating
EVs,
eliminating
need
prior
isolation.
Demonstrating
clinical
translation,
technology
detects
an
EV‐associated
epitope
signature
serum
plasma,
distinguishing
myocardial
infarction
stable
angina.
Additionally,
allow
tetraspanin‐lacking
Red
Blood
Cell‐derived
overcoming
limitations
associated
antibody‐based
methods.
Overall,
work
underlines
value
complementary
tools
antibodies,
advancing
EV
diagnostics
beyond,
marking
first‐ever
peptide‐based
application
SiMoA
technology.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Single
extracellular
vesicle
(EV)
research
holds
the
potential
to
revolutionize
our
understanding
of
cellular
communication
and
enable
breakthroughs
in
diagnostics
therapeutics.
However,
lack
a
clear,
consensus-driven
definition
single
EV
has
led
methodological
inconsistencies,
overgeneralized
interpretations,
and,
some
cases,
misleading
claims.
In
this
perspective,
we
propose
framework
for
defining
research,
critique
current
challenges
misconceptions
field,
discuss
its
implications
biomedical
applications.
We
argue
that
precise
experimental
design,
rigorous
validation,
interdisciplinary
collaboration
approaches
are
needed
establish
as
cornerstone
precision
medicine.
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 125667 - 125667
Published: April 1, 2025
Aerobic
vaginitis
is
an
infectious
disease
characterized
by
the
overgrowth
of
abnormal
vaginal
microflora.
Conventional
local
dosage
forms
are
not
always
effective,
due
to
their
inadequate
drug
release
and
residence
time
within
cavity.
Therefore,
this
study
aimed
develop
azithromycin
(AZT)-loaded
liposomes,
coated
with
two
mucoadhesive
polymers,
chitosan
(CS)
sodium
hyaluronate
(HYA),
increase
thedrug's
stay
at
site
infection
control
its
release.
Liposomes
were
developed
through
thin
film
hydration
method
followed
extrusion
subsequently
added
polymer
solution.
Later,
they
size,
surface
charge,
morphology,
encapsulation
efficiency.
Furthermore,
properties
behavior
investigated
different
pH
values,
e.g.,
4.5
7.4,
mimicking
physiological
pathological
conditions,
respectively.
Finally,
antimicrobial
tests
in
vitro
permeation
studies
carried
out.
Results
showed
size
charge
variations
LP
respect
uncoated
ones,
confirming
success
coating
process.
possessed
a
good
capacity
encapsulate
drug.
Among
all
formulations,
CS-LP
demonstrated
superior
greatest
both
tested
pHs,
as
well
highest
accumulation
inside
tissue,
maintaining
same
AZT
effect.
Overall,
could
be
proposed
promising
nanocarrier
for
delivery,
virtue
ability
achieve
locally
sustained
drug,
helping
lower
administration
frequency,
consequently
improving
treatment
efficacy.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 27, 2025
AbstractBackground
The
extracellular
vesicle
(EV)
pathway
plays
a
critical
role
in
cell-to-cell
communication.
Cancer
cells
release
EVs
into
the
space,
where
they
interact
with
both
cancerous
and
noncancerous
cells,
activating
signaling
pathways
remodeling
tumor
microenvironment
(TME).
In
this
study,
we
investigated
functional
of
released
by
FGFR2-amplified
cancers
unknown
primary
(CUPs),
which
generate
extrachromosomal
circular
DNA
(ecDNA)
to
enhance
oncogenic
amplification.Methods
FGFR2
copy
number
was
quantified
using
droplet
digital
PCR
(ddPCR)
visualized
fluorescent
situ
hybridization
(FISH).
were
isolated
via
ultracentrifugation,
nature
ecDNA
assessed
Plasmid-Safe
ATP-dependent
DNase
treatment
atomic
force
microscopy
(AFM).
Oncogene
transfer
through
evaluated
administering
CUP-derived
recipient
NCI-N87
or
coculture
system
that
facilitated
EV
THP-1,
HUVEC,
fibroblast
cell
lines.Results
FGFR2-containing
ecDNA,
is
partially
circular,
packaged
within
exhibited
activity
upon
delivery
TME
cells.
When
cancer
(NCI-N87,
THP-1)
noncancer
(HUVECs,
fibroblasts)
exposed
EVs—either
direct
administration
coculture—they
internalized
DNA,
subsequently
transcribed,
leading
altered
morphology
increased
proliferation,
depending
on
type.
induced
THP-1
polarization
toward
M2
macrophage
subtype
promoted
HUVEC
proliferation.Conclusion
This
mechanism
oncogene
can
contribute
remodeling,
potentially
explaining
early
metastatic
potential
CUP.